Low-Cost Contingency Management for Smoking Cessation
| Status: | Completed |
|---|---|
| Conditions: | Smoking Cessation |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 6/7/2018 |
| Start Date: | June 2009 |
| End Date: | May 2012 |
An innovative low-cost form of contingency management has been developed in which
participants receive the chance to draw vouchers from a fish bowl depending on whether or not
their abstinence from tobacco is confirmed by expired-air carbon monoxide. The vouchers can
be redeemed for prizes of varying value. This form of contingency management has been shown
to be effective in the treatment of a variety of substance use disorders, but has not been
investigated in a clinical trial focusing on smoking cessation. Thus, the primary purpose of
the proposed study will be to investigate the effects of a low-cost prize-based form of
contingency management in the treatment of nicotine dependence. To accomplish this objective,
we enrolled 103 current smokers into the study. The participants in Study Arm 1 received the
contingency management intervention for 8 weeks, and the participants in Study Arm 2 had
their smoking status assessed but did not receive the contingency management intervention.
Both interventions received brief counseling and nicotine replacement therapy. The counseling
was conducted in two 60-minute individual sessions scheduled one week apart with two
follow-up phone calls at weeks 3, 4, and 6.
The primary outcome for this study was biochemically-validated smoking status at 3 months
(end of treatment), and at 6- and 12-month follow-up. Both continuous and point-prevalent
abstinence rates were determined. Saliva cotinine levels were measured in all participants
reporting abstinence at each assessment. This study had 80% power to detect a 10% absolute
difference in smoking cessation rates between the two treatment conditions (i.e., a 28% quit
rate in Study Arm 1 versus a 18% quit rate in Study Arm 2) with alpha set at 0.05. These
estimates included an anticipated 15% loss to follow-up over the 12-month study period.
participants receive the chance to draw vouchers from a fish bowl depending on whether or not
their abstinence from tobacco is confirmed by expired-air carbon monoxide. The vouchers can
be redeemed for prizes of varying value. This form of contingency management has been shown
to be effective in the treatment of a variety of substance use disorders, but has not been
investigated in a clinical trial focusing on smoking cessation. Thus, the primary purpose of
the proposed study will be to investigate the effects of a low-cost prize-based form of
contingency management in the treatment of nicotine dependence. To accomplish this objective,
we enrolled 103 current smokers into the study. The participants in Study Arm 1 received the
contingency management intervention for 8 weeks, and the participants in Study Arm 2 had
their smoking status assessed but did not receive the contingency management intervention.
Both interventions received brief counseling and nicotine replacement therapy. The counseling
was conducted in two 60-minute individual sessions scheduled one week apart with two
follow-up phone calls at weeks 3, 4, and 6.
The primary outcome for this study was biochemically-validated smoking status at 3 months
(end of treatment), and at 6- and 12-month follow-up. Both continuous and point-prevalent
abstinence rates were determined. Saliva cotinine levels were measured in all participants
reporting abstinence at each assessment. This study had 80% power to detect a 10% absolute
difference in smoking cessation rates between the two treatment conditions (i.e., a 28% quit
rate in Study Arm 1 versus a 18% quit rate in Study Arm 2) with alpha set at 0.05. These
estimates included an anticipated 15% loss to follow-up over the 12-month study period.
Contingency management as a treatment for substance use disorders involves the use of
tangible rewards for confirmed abstinence. There is preliminary evidence that contingency
management shows promise as a smoking cessation intervention. An innovative low-cost form of
contingency management has been developed in which participants receive the chance to draw
vouchers from a fish bowl depending on whether or not their abstinence from tobacco is
confirmed by expired-air carbon monoxide. The vouchers can be redeemed for prizes of varying
value. This form of contingency management has been shown to be effective in the treatment of
a variety of substance use disorders, but has not been investigated in a clinical trial
focusing on smoking cessation. Thus, the primary purpose of the proposed study was to
investigate the effects of a low-cost prize-based form of contingency management in the
treatment of nicotine dependence. To accomplish this objective, we enrolled 103 current
smokers into the study. The participants in Study Arm 1 received the contingency management
intervention for 8 weeks, and the participants in Study Arm 2 had their smoking status
assessed but did not receive the contingency management intervention. Both interventions
received brief counseling and nicotine replacement therapy. The counseling was conducted in
two 60-minute individual sessions scheduled one week apart with two follow-up phone calls at
weeks 3, 4, and 6.
The primary outcome for this study was biochemically-validated smoking status at 3 months
(end of treatment), and at 6- and 12-month follow-up. Both continuous and point-prevalent
abstinence rates were determined. Saliva cotinine levels were measured in all participants
reporting abstinence at each assessment. This study had 80% power to detect a 10% absolute
difference in smoking cessation rates between the two treatment conditions (i.e., a 28% quit
rate in Study Arm 1 versus a 18% quit rate in Study Arm 2) with alpha set at 0.05. These
estimates included an anticipated 15% loss to follow-up over the 12-month study period.
tangible rewards for confirmed abstinence. There is preliminary evidence that contingency
management shows promise as a smoking cessation intervention. An innovative low-cost form of
contingency management has been developed in which participants receive the chance to draw
vouchers from a fish bowl depending on whether or not their abstinence from tobacco is
confirmed by expired-air carbon monoxide. The vouchers can be redeemed for prizes of varying
value. This form of contingency management has been shown to be effective in the treatment of
a variety of substance use disorders, but has not been investigated in a clinical trial
focusing on smoking cessation. Thus, the primary purpose of the proposed study was to
investigate the effects of a low-cost prize-based form of contingency management in the
treatment of nicotine dependence. To accomplish this objective, we enrolled 103 current
smokers into the study. The participants in Study Arm 1 received the contingency management
intervention for 8 weeks, and the participants in Study Arm 2 had their smoking status
assessed but did not receive the contingency management intervention. Both interventions
received brief counseling and nicotine replacement therapy. The counseling was conducted in
two 60-minute individual sessions scheduled one week apart with two follow-up phone calls at
weeks 3, 4, and 6.
The primary outcome for this study was biochemically-validated smoking status at 3 months
(end of treatment), and at 6- and 12-month follow-up. Both continuous and point-prevalent
abstinence rates were determined. Saliva cotinine levels were measured in all participants
reporting abstinence at each assessment. This study had 80% power to detect a 10% absolute
difference in smoking cessation rates between the two treatment conditions (i.e., a 28% quit
rate in Study Arm 1 versus a 18% quit rate in Study Arm 2) with alpha set at 0.05. These
estimates included an anticipated 15% loss to follow-up over the 12-month study period.
Inclusion Criteria:
- Smoke at least 5 cigarettes per day
- Interested in quitting
Exclusion Criteria:
- Cognitive impairment or unstable psychotic disorder that would significantly interfere
with the individual's ability to participate in the study.
- Self-reported problem with alcohol or other drugs during the past three months
- Current use of any smoking cessation medication
- Presence of any contraindications for nicotine patches, lozenges, or gum
- Pregnancy
We found this trial at
1
site
Click here to add this to my saved trials
